Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
70 participants
OBSERVATIONAL
2011-10-31
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Antioxidants in Unexplained Oligohydramnios,A Randomized Trial
NCT01990690
Maternal Serum Homocysteine Levels and Uterine Artery Pulsatility Indices in Preterm Labor
NCT03440281
The Association Between Parathyroid Hormone and Preterm Labor
NCT05688007
Uterocervical Angle in Prediction of Preterm Labor
NCT05632003
Are Uterine Natural Killer Cells Involved in the Initiation of Preterm Labor ?
NCT02284867
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a prospective case-control study.
Setting:
The study will be conducted at Ain Shams University Maternity Hospital.
Population of the study:
A total of 70 pregnant women attending the outpatient obstetric clinic and inpatient of Obstetrics and Gynecology department or when they will be admitted to the delivary room of Ain Shams university hospital.
Patient will be divided in to two groups. Group A: 35 pregnant women diagnosed with preterm labor(Preterm labor pain at least 3 contraction every 20 minutes ,cervical dilatation \< 2cm and effacement\< 50%) which will deliver within one week maximum after hospitalization.
Group B: 35 pregnant women( controls )with uncomplicated pregnancies at a similar gestational ages followed routinely in the antenatal care unit.
Every case will be subjected to:-
1. Written informed consent before the study.
2. Complete history .
3. Complete general and abdominal examination.
4. Infection markers(CRP,WBCs count, urine analysis ).
5. Gestational age determination by the last menstrual date or Ultrasonography.
6. Local pelvic examination.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
preterm labor cases
Group A: 35 pregnant women diagnosed with preterm labor(Preterm labor pain at least 3 contraction every 20 minutes ,cervical dilatation \< 2cm and effacement\< 50%) which will deliver within one week maximum after hospitalization.
No interventions assigned to this group
control group
Group B: 35 pregnant women( controls )with uncomplicated pregnancies at a similar gestational ages followed routinely in the antenatal care unit.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Singleton pregnancy.
* Amnion membranes were intact
Exclusion Criteria
* Urinary tract infections and any other infections.
* Poly- or oligohydramnios.
* Fetal distress, fetal or uterine anomaly.
* Membranes rupture and placenta pathology.
* Preeclampsia or intrauterine growth retardation
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams Maternity Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abdallah Salah Abdelatif
THE ROLE OF SERUM TOTAL ANTI OXIDANT IN PRETERM LABOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ABDALLAH s ABDELATIF, residant
Role: PRINCIPAL_INVESTIGATOR
Ain Shams Maternity Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams Maternity Hospital
Cairo, Tertiary, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Mohamed SE elsafty, lecturer
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Mohamed SE Elsafty, lecturer
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ABDO-0100
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.